Update to the structured MRI report for primary staging of rectal cancer : Perspective from the SAR Disease Focused Panel on Rectal and Anal Cancer.


Journal

Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571

Informations de publication

Date de publication:
10 2022
Historique:
received: 21 04 2022
accepted: 30 06 2022
revised: 29 06 2022
pubmed: 27 7 2022
medline: 14 9 2022
entrez: 26 7 2022
Statut: ppublish

Résumé

To review existing structured MRI reports for primary staging of rectal cancer and create a new, freely available structured report based on multidisciplinary expert opinion and literature review. Twenty abdominal imaging experts from the Society of Abdominal Radiology (SAR)'s Disease Focused Panel (DFP) on Rectal and Anal Cancer completed a questionnaire and participated in a subsequent consensus meeting based on the RAND-UCLA Appropriateness Method. Twenty-two items were classified via a group survey as "appropriate" or "inappropriate" (defined by ≥ 70% consensus), or "needs group discussion" (defined by < 70% consensus). Certain items were also discussed with multidisciplinary team members from colorectal surgery, oncology and pathology. After completion of the questionnaire, 16 (72%) items required further discussion (< 70% consensus). Following group discussion, consensus was achieved for 21 (95%) of the items. Based on the consensus meeting, a revised structured report was developed. The most significant modifications included (1) Exclusion of the T2/early T3 category; (2) Replacement of the term "circumferential resection margin (CRM)" with "mesorectal fascia (MRF)"; (3) A revised definition of "mucinous content"; (4) Creation of two distinct categories for suspicious lymph nodes (LNs) and tumor deposits; and (5) Classification of suspicious extra-mesorectal LNs by anatomic location. The SAR DFP on Rectal and Anal Cancer recommends using this newly updated reporting template for primary MRI staging of rectal cancer.

Identifiants

pubmed: 35881198
doi: 10.1007/s00261-022-03612-3
pii: 10.1007/s00261-022-03612-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3364-3374

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Siegel, R.L., et al., Colorectal cancer statistics, 2020. CA Cancer J Clin, 2020. 70(3): p. 145–164.
doi: 10.3322/caac.21601
Keller, D.S., et al., The multidisciplinary management of rectal cancer. Nat Rev Gastroenterol Hepatol, 2020. 17(7): p. 414–429.
doi: 10.1038/s41575-020-0275-y
Horvat, N., et al., MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management. Radiographics, 2019. 39(2): p. 367–387.
doi: 10.1148/rg.2019180114
Brown, P.J., et al., Standardised reports with a template format are superior to free text reports: the case for rectal cancer reporting in clinical practice. Eur Radiol, 2019. 29(9): p. 5121–5128.
doi: 10.1007/s00330-019-06028-8
Beets-Tan, R.G.H., et al., Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol, 2018. 28(4): p. 1465–1475.
doi: 10.1007/s00330-017-5026-2
Gollub, M.J., et al., Use of magnetic resonance imaging in rectal cancer patients: Society of Abdominal Radiology (SAR) Rectal Cancer Disease-Focused Panel (DFP) recommendations 2017. Abdom Radiol (NY), 2018. 43(11): p. 2893–2902.
doi: 10.1007/s00261-018-1642-9
Kennedy, E.D., et al., Development and implementation of a synoptic MRI report for preoperative staging of rectal cancer on a population-based level. Dis Colon Rectum, 2014. 57(6): p. 700–8.
doi: 10.1097/DCR.0000000000000123
Fitch, K., et al., The RAND/UCLA Appropriateness Method User’s Manual. 2001, AHCPR Pub No 95-0009. Public Health Service, US Department of Health and HumanServices, Rockville.
Al-Sukhni, E., et al., User’s Guide for the Synoptic MRI Report for Pre-Operative Staging of Rectal Cancer. 2015, Cancer Care Ontario.
Diamond, I.R., et al., Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol, 2014. 67(4): p. 401–9.
doi: 10.1016/j.jclinepi.2013.12.002
Jhaveri, K.S., et al., MRI Detection of Extramural Venous Invasion in Rectal Cancer: Correlation with Histopathology Using Elastin Stain. American Journal of Roentgenology, 2016. 206(4): p. 747–755.
doi: 10.2214/AJR.15.15568
Zhang, X.Y., et al., MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival. Radiology, 2018. 289(3): p. 677–685.
doi: 10.1148/radiol.2018172889
Sigurdsson, H.K., et al., Rectal cancer with macroscopic peritoneal involvement—clinical challenges and consequences. Colorectal Dis, 2009. 11(8): p. 838–44.
doi: 10.1111/j.1463-1318.2008.01700.x
Gollub, M.J., et al., Occurrence of peritoneal carcinomatosis in patients with rectal cancer undergoing staging pelvic MRI: clinical observations. Eur Radiol, 2022.
Hamilton, S., F. Bosman, and P. Boffetta, Carcinoma of the colon and rectum, in WHO Classification of Tumours of the Digestive System., C.F. Bosman FT, Hruban RH, Theise ND, Editor. 2010, IARC Press. p. 134–146.
Amin, M.B., et al., The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin, 2017. 67(2): p. 93–99.
Lord, A.C., et al., MRI-Diagnosed Tumour Deposits and EMVI Status Have Superior Prognostic Accuracy to Current Clinical TNM Staging in Rectal Cancer. Ann Surg, 2020.
Ogura, A., et al., Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated with Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy. JAMA Surg, 2019. 154(9): p. e192172.
doi: 10.1001/jamasurg.2019.2172
Zheng, K., et al., The Prognostic Significance of Tumor Deposit Count for Colorectal Cancer Patients After Radical Surgery. Gastroenterol Res Pract, 2020. 2020: p. 2052561.
pubmed: 32256564 pmcid: 7103057
Jin, M., et al., The impact of tumor deposits on colonic adenocarcinoma AJCC TNM staging and outcome. Am J Surg Pathol, 2015. 39(1): p. 109–15.
doi: 10.1097/PAS.0000000000000320
Inoue, A., et al., MRI-detected extramural venous invasion of rectal cancer: Multimodality performance and implications at baseline imaging and after neoadjuvant therapy. Insights Imaging, 2021. 12(1): p. 110.
doi: 10.1186/s13244-021-01023-4
Compton, C.C., Pathologic prognostic factors in the recurrence of rectal cancer. Clin Colorectal Cancer, 2002. 2(3): p. 149–60.
doi: 10.3816/CCC.2002.n.020

Auteurs

Zahra Kassam (Z)

Western University, London, ON, Canada. Zahra.kassam@sjhc.london.on.ca.
Department of Medical Imaging, St. Joseph's Hospital, Schulich School of Medicine Western University, 268 Grosvenor Street, London, ON, N6A 4V2, Canada. Zahra.kassam@sjhc.london.on.ca.

Rebecca Lang (R)

Western University, London, ON, Canada.

Supreeta Arya (S)

Tata Memorial Centre, Mumbai, India.

David D B Bates (DDB)

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Kevin J Chang (KJ)

Boston University, Boston, MA, USA.

Tyler J Fraum (TJ)

Mallinckrodt Institute of Radiology, St. Louis, MO, USA.

Kenneth A Friedman (KA)

Cleveland Medical Center, Cleveland, OH, USA.

Jennifer S Golia Pernicka (JS)

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Marc J Gollub (MJ)

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Mukesh Harisinghani (M)

Massachusetts General Hospital, Boston, MA, USA.

Gaurav Khatri (G)

University of Texas Southwestern, Dallas, TX, USA.

Elena Korngold (E)

Oregon Health & Science University, Portland, OR, USA.

Chandana Lall (C)

University of Florida-Jacksonville, Jacksonville, FL, USA.

Sonia Lee (S)

University of California-Irvine, Irvine, CA, USA.

Michael Magnetta (M)

Northwestern University, Evanston, IL, USA.

Courtney Moreno (C)

Emory University School of Medicine, Atlanta, GA, USA.

Stephanie Nougaret (S)

Montpellier Cancer Institute, Montpellier University, Montpellier, France.

Viktoriya Paroder (V)

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Raj M Paspulati (RM)

Case Western Reserve University, Cleveland, OH, USA.

Iva Petkovska (I)

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Perry J Pickhardt (PJ)

University of Wisconsin, Madison, WI, USA.

Hiram Shaish (H)

Columbia University, New York, NY, USA.

Shannon Sheedy (S)

Mayo Clinic Rochester, Rochester, MN, USA.

Martin R Weiser (MR)

Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Lisa Xuan (L)

Western University, London, ON, Canada.

David H Kim (DH)

University of Wisconsin, Madison, WI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH